The Evidence Is In: Australia Recommends Breast Implant Ban
The Therapeutic Goods Administration says it now has enough evidence to warrant cancelling, suspending and recalling a number of textured breast implants because of the potential risks of developing anaplastic large cell lymphoma.
You may also be interested in...
Allergan PLC announced that it would take its Biocell textured breast implants and tissue expanders off the market worldwide shortly after the US FDA released additional information linking the use of the implants to a rare cancer.
There is now enough safety evidence to merit withdrawing macro-textured and polyurethane-coated breast implants from the market, according to health product regulators in France and Canada.
Zolgensma should receive a conditional approval, says the European Medicines Agency’s drug evaluation committee, the CHMP.